Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 18 X users

Citations

dimensions_citation: 89 Dimensions

Readers on

mendeley: 100 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 89 publications that cite this research output.

89

The most recent citing publications are shown below. View all 89 publications that cite this research output on Dimensions.

The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis.

Article in PLOS ONE (February 2024)

Single-port video-assisted thoracoscopic sleeve lobectomy after neoadjuvant immunochemotherapy: a case report

Article in Translational Lung Cancer Research (February 2024)

Initial Safety and Feasibility Results From a Phase 1, Diagnose-and-Treat Trial of Neoadjuvant Intratumoral Cisplatin for Stage IV NSCLC

Article in JTO Clinical and Research Reports (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.